[
    {
        "pregunta": "1. Which bacterial species is the causative agent of Lyme disease?",
        "respuesta": "The bacterial species that causes Lyme disease is **Borrelia burgdorferi**.",
        "contexto": [
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI.",
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "of Health and Human Services Tick-Borne Disease Working Group Dr. Wormser Immunetics, Inc., Rarecyte, Inc., Institute for Systems Biology Quidel Corporation American Lyme Disease Foundation Abbott Laboratories CDC, NIH, BioMérieux, Bio-Rad Laboratories DiaSorin, Inc; has served as a scientific research advisor for Baxter International and as a Lyme disease advisor and expert for the Missouri Board of Registration for the Healing Arts 10 669 567 B2 High Sensitivity Method for Early Lyme Disease",
            "for or against the use of antibiotics (no recommendation; knowledge gap). Comment: In certain geographic regions both STARI and Lyme disease are endemic . Distinguishing single erythema migrans due to Lyme disease from STARI may not be possible clinically unless the responsible tick has been identified IX. What is the preferred diagnostic testing strategy for Lyme neuroborreliosis? Recommendations: 1. When assessing patients for possible Lyme neuroborreliosis involving either the peripheral",
            "a National Lyme Disease Strategy on behalf of the Association of Medical Microbiology and Infectious Disease Canada; and has received research funding from GlaxoSmithKline, Pfizer Canada, the Canadian Institutes of Health Research, and Vancouver Coastal Health Research Institute. Dr. Branda receives research funding from the Lyme Disease Biobank Foundation and Zeus Scientific; serves as a scientific advisor and consultant to DiaSorin, Inc.; has served as a scientific advisor and consultant for"
        ]
    },
    {
        "pregunta": "2. What pacing modality is recommended for symptomatic bradycardia due to Lyme carditis that cannot be managed medically?",
        "respuesta": "For patients with symptomatic bradycardia due to Lyme carditis that cannot be managed medically, the guideline **strongly recommends the use of temporary pacing modalities rather than implanting a permanent pacemaker** (strong recommendation, moderate-quality evidence).",
        "contexto": [
            "exercise intolerance, palpitations, presyncope, syncope, pericarditic pain, evidence of pericardial effusion, elevated biomarkers (such as troponin), edema, and shortness of breath. XVIII. What pacing modality should be used if needed for the management of Lyme carditis? Recommendation: 1. For patients with symptomatic bradycardia due to Lyme carditis that cannot be managed medically, we recommend temporary pacing modalities rather than implanting a permanent pacemaker (strong recommendation,",
            "rather than implanting a permanent pacemaker (strong recommendation, moderate-quality evidence). XIX. What are the preferred antibiotic regimens for the treatment of Lyme carditis? Recommendations: 1. In outpatients with Lyme carditis, we suggest oral antibiotics over IV antibiotics (weak recommendation, very low-quality evidence). 2. In the hospitalized patient with Lyme carditis, we suggest initially using IV ceftriaxone over oral antibiotics until there is evidence of clinical improvement,",
            "hospitalization? Recommendation: 1. In patients with or at risk for severe cardiac complications of Lyme disease including those with significant PR prolongation (PR >300 milliseconds), other arrhythmias, or clinical manifestations of myopericarditis, we recommend hospital admission with continuous ECG monitoring (strong recommendation, very low-quality evidence). Comment: Clinical manifestations of Lyme carditis include exercise intolerance, palpitations, presyncope, syncope, pericarditic",
            "disease receive an electrocardiogram (ECG) to screen for Lyme carditis? Recommendation: 1. We suggest performing an ECG only in patients with signs or symptoms consistent with Lyme carditis (weak recommendation, low-quality evidence). Comment: Symptoms and signs of cardiac involvement in Lyme disease include dyspnea, edema, palpitations, lightheadedness, chest pain, and syncope. XVII. Which patients with Lyme carditis require hospitalization? Recommendation: 1. In patients with or at risk for",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS"
        ]
    },
    {
        "pregunta": "3. What are the three criteria that define a high-risk tick bite warranting prophylactic antibiotics?",
        "respuesta": "The three criteria that define a high-risk tick bite warranting prophylactic antibiotic treatment are:\n\n1. The tick bite was from an identified **Ixodes spp.** vector species.  \n2. The bite occurred in a **highly endemic area** for Lyme disease.  \n3. The tick was attached for **≥36 hours**.\n\nIf all these criteria are met, a single dose of oral doxycycline within 72 hours of tick removal is recommended for prophylaxis.",
        "contexto": [
            "a wait-and-watch approach is recommended. A tick bite is considered to be high-risk only if it meets the following 3 criteria: the tick bite was from (a) an identified Ixodes spp. vector species, (b) it occurred in a highly endemic area, and (c) the tick was attached for ≥36 hours. IV. What is the preferred antibiotic regimen for the chemoprophylaxis of Lyme disease following a high-risk tick bite? Recommendation: 1. For high-risk Ixodes spp. bites in all age groups, we recommend the",
            "disease following presentation with a tick bite? Recommendation: 1. We recommend that prophylactic antibiotic therapy be given only to adults and children within 72 hours of removal of an identified high-risk tick bite, but not for bites that are equivocal risk or low risk (strong recommendation, high-quality evidence). Comment: If a tick bite cannot be classified with a high level of certainty as a high-risk bite, a wait-and-watch approach is recommended. A tick bite is considered to be",
            "Recommendations: 1. We recommend submitting the removed tick for species identification (good practice statement). are identical except for minor stylistic and spelling differences in keeping with each journal's style. The full guideline is available at http://onlin elibr ary. wiley.com/doi/10.1002/art.41562/ abstract We recommend against testing a removed III. Who should receive antibiotic prophylaxis to prevent Lyme disease following presentation with a tick bite? Recommendation: 1. We",
            "in the United States, as this duration of therapy was used in the largest clinical trial performed in the United States . VIII. Should patients with the southern tickassociated rash illness (STARI) be treated with antibiotics? Recommendation: 1. In patients who develop an erythema migrans-like skin lesion following the bite of the lone star tick (Amblyomma americanum), an illness referred to as STARI, we make no recommendation for or against the use of antibiotics (no recommendation; knowledge",
            "1. For high-risk Ixodes spp. bites in all age groups, we recommend the administration of a single dose of oral doxycycline within 72 hours of tick removal over observation (strong recommendation, moderate-quality evidence). Comment: Doxycycline is given as a single oral dose, 200 mg for adults and 4.4 mg/kg (up to a maximum dose of 200 mg) for children. V. What is the preferred diagnostic testing strategy for erythema migrans? Recommendations: 1. In patients with potential tick exposure in a"
        ]
    },
    {
        "pregunta": "4. Can Lyme disease cause neurological complications? If so, name two common neurologic manifestations.",
        "respuesta": "Yes, Lyme disease can cause neurological complications. Two common neurologic manifestations are:\n\n1. Lyme disease-associated meningitis  \n2. Cranial neuropathy (such as facial nerve palsy)\n\nOther recognized manifestations include radiculoneuropathy and involvement of the peripheral nervous system.",
        "contexto": [
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI.",
            "3. In patients with neurologic syndromes other than those listed in XI. Should adult patients with psychiatric illnesses be tested for Lyme disease? Recommendation: 1. In patients with psychiatric illness, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). XII. Should children with developmental, behavioral, or psychiatric disorders be tested for Lyme disease? Recommendation: 1. In children presenting with developmental, behavioral, or"
        ]
    },
    {
        "pregunta": "5. How long is the usual duration of antibiotic therapy for early Lyme disease?",
        "respuesta": "The usual duration of antibiotic therapy for early Lyme disease is **14 to 21 days** of oral antibiotics. This duration is preferred based on weak recommendation and very low-quality evidence.",
        "contexto": [
            "1. In patients with acrodermatitis chronica atrophicans, we suggest oral antibiotic therapy for 21-28 days over shorter durations (weak recommendation, low-quality evidence). XXVIII. Under what circumstances should a patient with Lyme disease be evaluated for coinfection with A. phagocytophilum or B. microti? Recommendation: 1 To provide thorough transparency, the IDSA/AAN/ACR requires full disclosure of all relationships, regardless of relevancy to the guideline topic. The assessment of",
            "as side effect profile, ease of administration, ability to tolerate oral medication, concerns about compliance unrelated to effectiveness. Treatment route may be changed from IV to oral during treatment. The preferred antibiotic duration is 14-21 days. XIV. Should patients with Lyme disease-related parenchymal involvement of the brain or spinal cord be treated with oral or intravenous antibiotics? Recommendation: 1. In patients with Lyme disease-associated parenchymal involvement of the brain",
            "over oral antibiotics until there is evidence of clinical improvement, then switching to oral antibiotics to complete treatment (weak recommendation, very low-quality evidence). 3. For the treatment of Lyme carditis, we suggest 14-21 days of total antibiotic therapy over longer durations of treatment (weak recommendation, very low-quality evidence). Comment: Oral antibiotic choices for Lyme carditis are doxycycline, amoxicillin, cefuroxime axetil, and azithromycin. XX. Should patients being",
            "using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence). XXIII. What are the approaches to patients in whom Lyme arthritis has not completely resolved? Recommendations: 1. In patients with Lyme arthritis with partial response (mild residual joint swelling) after a first course of oral antibiotic, we make no recommendation for a second course of antibiotic versus observation (no recommendation, knowledge gap). Comment: Consideration should be given to",
            "activity, such as arthritis, meningitis, or neuropathy. XXVI. What is the preferred antibiotic regimen for the treatment of borrelial lymphocytoma? Recommendation: 1. In patients with borrelial lymphocytoma, we suggest oral antibiotic therapy for 14 days (weak recommendation, lowquality evidence). XXVII. What is the preferred antibiotic regimen for the treatment of acrodermatitis chronica atrophicans? Recommendation: 1. In patients with acrodermatitis chronica atrophicans, we suggest oral"
        ]
    },
    {
        "pregunta": "6. What is the recommended duration of antibiotic therapy for acute neurologic Lyme disease without parenchymal involvement?",
        "respuesta": "The recommended duration of antibiotic therapy for acute neurologic Lyme disease without parenchymal involvement (such as Lyme meningitis, cranial neuropathy, or radiculoneuropathy) is **14 to 21 days** of oral antibiotics. This duration is supported by weak recommendation and very low-quality evidence according to the provided guideline information.",
        "contexto": [
            "as side effect profile, ease of administration, ability to tolerate oral medication, concerns about compliance unrelated to effectiveness. Treatment route may be changed from IV to oral during treatment. The preferred antibiotic duration is 14-21 days. XIV. Should patients with Lyme disease-related parenchymal involvement of the brain or spinal cord be treated with oral or intravenous antibiotics? Recommendation: 1. In patients with Lyme disease-associated parenchymal involvement of the brain",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "1. In patients with acrodermatitis chronica atrophicans, we suggest oral antibiotic therapy for 21-28 days over shorter durations (weak recommendation, low-quality evidence). XXVIII. Under what circumstances should a patient with Lyme disease be evaluated for coinfection with A. phagocytophilum or B. microti? Recommendation: 1 To provide thorough transparency, the IDSA/AAN/ACR requires full disclosure of all relationships, regardless of relevancy to the guideline topic. The assessment of",
            "using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence). XXIII. What are the approaches to patients in whom Lyme arthritis has not completely resolved? Recommendations: 1. In patients with Lyme arthritis with partial response (mild residual joint swelling) after a first course of oral antibiotic, we make no recommendation for a second course of antibiotic versus observation (no recommendation, knowledge gap). Comment: Consideration should be given to",
            "over oral antibiotics until there is evidence of clinical improvement, then switching to oral antibiotics to complete treatment (weak recommendation, very low-quality evidence). 3. For the treatment of Lyme carditis, we suggest 14-21 days of total antibiotic therapy over longer durations of treatment (weak recommendation, very low-quality evidence). Comment: Oral antibiotic choices for Lyme carditis are doxycycline, amoxicillin, cefuroxime axetil, and azithromycin. XX. Should patients being"
        ]
    },
    {
        "pregunta": "7. What are the typical clinical features of early localized Lyme disease?",
        "respuesta": "The typical clinical features of early localized Lyme disease include the presence of **erythema migrans**, which is a characteristic skin lesion(s) appearing at the site of the tick bite. Patients often have one or more skin lesions compatible with erythema migrans. No laboratory testing is generally required to confirm the diagnosis if such lesions are present in the context of potential tick exposure in a Lyme disease endemic area.\n\nAdditional features are not detailed in the provided information, so further specific symptoms of early localized Lyme disease cannot be reliably stated based on the available data.",
        "contexto": [
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "migrans? Recommendations: 1. In patients with potential tick exposure in a Lyme disease endemic area who have 1 or more skin lesions compatible with erythema migrans, we recommend clinical diagnosis rather than laboratory testing (strong recommendation, moderatequality evidence). 2. In patients with 1 or more skin lesions suggestive of, but atypical for erythema migrans, we suggest antibody testing performed on an acute-phase serum sample (followed by a convalescent-phase serum sample if the",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "hospitalization? Recommendation: 1. In patients with or at risk for severe cardiac complications of Lyme disease including those with significant PR prolongation (PR >300 milliseconds), other arrhythmias, or clinical manifestations of myopericarditis, we recommend hospital admission with continuous ECG monitoring (strong recommendation, very low-quality evidence). Comment: Clinical manifestations of Lyme carditis include exercise intolerance, palpitations, presyncope, syncope, pericarditic",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,"
        ]
    },
    {
        "pregunta": "8. What are the key differences between early localized and early disseminated Lyme disease?",
        "respuesta": "The provided guideline information describes **early localized Lyme disease** primarily by the presence of **erythema migrans** skin lesion(s) at the site of the tick bite, typically without requiring laboratory confirmation if clinical features and exposure are consistent.\n\nHowever, the guideline does **not provide specific details or descriptions regarding early disseminated Lyme disease**, including its clinical features or how it differs from early localized disease.\n\n**Therefore, based on the available information, a reliable response comparing early localized and early disseminated Lyme disease cannot be provided.**",
        "contexto": [
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "for or against the use of antibiotics (no recommendation; knowledge gap). Comment: In certain geographic regions both STARI and Lyme disease are endemic . Distinguishing single erythema migrans due to Lyme disease from STARI may not be possible clinically unless the responsible tick has been identified IX. What is the preferred diagnostic testing strategy for Lyme neuroborreliosis? Recommendations: 1. When assessing patients for possible Lyme neuroborreliosis involving either the peripheral",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI."
        ]
    },
    {
        "pregunta": "9. What is the recommended duration of antibiotic treatment for erythema migrans with doxycycline, amoxicillin, or cefuroxime axetil?",
        "respuesta": "The recommended duration of antibiotic treatment for erythema migrans is:\n\n- **10 days** of doxycycline, or  \n- **14 days** of amoxicillin or cefuroxime axetil.\n\nShorter or longer treatment courses than these are not recommended.  \n\nThis recommendation is a strong one based on moderate-quality evidence.",
        "contexto": [
            "VII. How long should a patient with erythema migrans be treated? Recommendation: 1. We recommend that patients with erythema migrans be treated with either a 10-day course of doxycycline or a 14-day course of amoxicillin or cefuroxime axetil rather than longer treatment courses (strong recommendation, moderatequality evidence). Comment: If azithromycin is used, the indicated duration is 5-10 days, with a 7-day course preferred in the United States, as this duration of therapy was used in the",
            "VI. What are the preferred antibiotic regimens for the treatment of erythema migrans? Recommendation: 1. For patients with erythema migrans, we recommend using oral antibiotic therapy with doxycycline, amoxicillin, or cefuroxime axetil (strong recommendation; moderate-quality evidence). Comment: For patients unable to take both doxycycline and beta-lactam antibiotics, the preferred second-line agent is azithromycin. VII. How long should a patient with erythema migrans be treated?",
            "1. For high-risk Ixodes spp. bites in all age groups, we recommend the administration of a single dose of oral doxycycline within 72 hours of tick removal over observation (strong recommendation, moderate-quality evidence). Comment: Doxycycline is given as a single oral dose, 200 mg for adults and 4.4 mg/kg (up to a maximum dose of 200 mg) for children. V. What is the preferred diagnostic testing strategy for erythema migrans? Recommendations: 1. In patients with potential tick exposure in a",
            "1. In patients with acrodermatitis chronica atrophicans, we suggest oral antibiotic therapy for 21-28 days over shorter durations (weak recommendation, low-quality evidence). XXVIII. Under what circumstances should a patient with Lyme disease be evaluated for coinfection with A. phagocytophilum or B. microti? Recommendation: 1 To provide thorough transparency, the IDSA/AAN/ACR requires full disclosure of all relationships, regardless of relevancy to the guideline topic. The assessment of",
            "activity, such as arthritis, meningitis, or neuropathy. XXVI. What is the preferred antibiotic regimen for the treatment of borrelial lymphocytoma? Recommendation: 1. In patients with borrelial lymphocytoma, we suggest oral antibiotic therapy for 14 days (weak recommendation, lowquality evidence). XXVII. What is the preferred antibiotic regimen for the treatment of acrodermatitis chronica atrophicans? Recommendation: 1. In patients with acrodermatitis chronica atrophicans, we suggest oral"
        ]
    },
    {
        "pregunta": "10. What is the proper technique for removing an attached tick to minimize risk of infection?",
        "respuesta": "The proper technique for removing an attached tick to minimize the risk of infection is to **promptly remove the tick by mechanical means using a clean fine-tipped tweezer (or a comparable device) inserted between the tick body and the skin**. This should be done carefully to avoid squeezing or crushing the tick.\n\nThe guidelines recommend against burning the tick with a match or other heat devices, or applying noxious chemicals or petroleum products to coax its detachment, as these practices are not advised.\n\nThis method is recommended as a good practice based on available guideline information.",
        "contexto": [
            "means using a clean fine-tipped tweezer (or a comparable device) inserted between the tick body and the skin (good practice statement). 2. We recommend against burning an attached tick (with a match or other heat device) or applying noxious chemicals or petroleum products to coax its detachment (good practice statement). II. Which diagnostic tests should be used following a tick bite? A. Diagnostic tick testing Recommendations: 1. We recommend submitting the removed tick for species",
            "bites Recommendation: 1. For the prevention of tick bites, we recommend N, N-Diethyl-meta-toluamide (DEET), picaridin, ethyl-3-(Nn-butyl-N-acetyl) aminopropionate (IR3535), oil of lemon eucalyptus (OLE), p-methane-3,8-diol (PMD), 2-undecanone, or permethrin (strong recommendation, moderate-quality evidence). C. Removal of attached ticks Recommendations: 1. We recommend promptly removing attached ticks by mechanical means using a clean fine-tipped tweezer (or a comparable device) inserted",
            "Recommendations: 1. We recommend submitting the removed tick for species identification (good practice statement). are identical except for minor stylistic and spelling differences in keeping with each journal's style. The full guideline is available at http://onlin elibr ary. wiley.com/doi/10.1002/art.41562/ abstract We recommend against testing a removed III. Who should receive antibiotic prophylaxis to prevent Lyme disease following presentation with a tick bite? Recommendation: 1. We",
            "http://onlin elibr ary.wiley.com/doi/10.1002/ art.41562/ abstract I. Which measures should be used to prevent tick bites and tick-borne infections? A. Personal protective measures Recommendation: 1. Individuals at risk of exposure should implement personal protective measures to reduce the risk of tick exposure and infection with tick-borne pathogens (good practice statement). B. Repellents to prevent tick bites Recommendation: 1. For the prevention of tick bites, we recommend N,",
            "a wait-and-watch approach is recommended. A tick bite is considered to be high-risk only if it meets the following 3 criteria: the tick bite was from (a) an identified Ixodes spp. vector species, (b) it occurred in a highly endemic area, and (c) the tick was attached for ≥36 hours. IV. What is the preferred antibiotic regimen for the chemoprophylaxis of Lyme disease following a high-risk tick bite? Recommendation: 1. For high-risk Ixodes spp. bites in all age groups, we recommend the"
        ]
    },
    {
        "pregunta": "11. What factors influence the geographic distribution and seasonality of Lyme disease?",
        "respuesta": "The provided guideline information does **not** include specific details regarding the factors that influence the geographic distribution and seasonality of Lyme disease. Therefore, a reliable response to this question cannot be given based on the available data.",
        "contexto": [
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI.",
            "for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists, and dermatologists in North America. Summarized below are the 2020 recommendations for the prevention, diagnosis, and treatment of Lyme disease. The panel followed a systematic process used in the development of other Infectious Diseases Society of",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,",
            "for or against the use of antibiotics (no recommendation; knowledge gap). Comment: In certain geographic regions both STARI and Lyme disease are endemic . Distinguishing single erythema migrans due to Lyme disease from STARI may not be possible clinically unless the responsible tick has been identified IX. What is the preferred diagnostic testing strategy for Lyme neuroborreliosis? Recommendations: 1. When assessing patients for possible Lyme neuroborreliosis involving either the peripheral"
        ]
    },
    {
        "pregunta": "12. The provided text appears to be a disclosures section from a clinical guideline document related to Lyme disease, listing conflicts of interest and funding sources of various experts. It does not contain clinical content, recommendations, or key concepts about Lyme disease itself. Therefore, it is not possible to generate meaningful clinical knowledge assessment questions specifically about Lyme disease based solely on this text.",
        "respuesta": "The provided disclosures section does **not** contain clinical content, recommendations, or key concepts about Lyme disease. It primarily lists affiliations, editorial boards, research grants, and potential conflicts of interest of individuals or organizations related to Lyme disease research and guidelines.\n\nTherefore, there is **no clinical or guideline content about Lyme disease** present in the disclosures section.",
        "contexto": [
            "Healing Arts 10 669 567 B2 High Sensitivity Method for Early Lyme Disease Detection 62/277 252 62/725 745 Editorial Boards for Clinical Infectious Diseases, Vector-Borne and Zoonotic Diseases, and Ticks and Tick-Borne Diseases Dr. Zemel Novartis Promotional Speakers Bureau ICMJE Form for Disclosure of Potential Conflicts of Interest  The article was peer reviewed by Arthritis & Rheumatology Clinical Infectious Diseases, Neurology, Arthritis Care & Research Arthritis & Rheumatology. Each   Yale",
            "Neurology, Arthritis Care & Research Arthritis & Rheumatology. Each   Yale Emerging Infections Program  L2  62/580  Editorial Board of Clinical Microbiology Reviews starting January 2021  Research Grant Council of Hong Kong  Steering Committee for the European Society of Clinical Microbiology and Infectious Diseases Study Group for Lyme Borreliosis  Canadian Lyme Disease Research Network and as a scientific advisor for the American Lyme Disease Association  10 DiaSorin, Inc; has served as a",
            "Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease  Roche Diagnostics  Abbott Laboratories (formerly St. Jude Medical  Centers for Medicare and Medicaid Services CMS  Michigan Department of Health and Human Services  Slovenian Research Agency  American Academy of Family Physicians AAFP  Global Lyme",
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "the American Lyme Disease Association  10 DiaSorin, Inc; has served as a scientific research advisor for Baxter International and as a Lyme disease advisor and expert for the Missouri Board of Registration for the Healing Arts  669  567 B2 High Sensitivity Method for Early Lyme Disease Detection  62/277  252  62/725  745   Editorial Board for Annals of Emergency Medicine"
        ]
    },
    {
        "pregunta": "13. However, based on general knowledge of Lyme disease clinical guidelines, here are 20 example questions that could be used to assess medical knowledge about Lyme disease:",
        "respuesta": "Based strictly on the provided guideline excerpts and available information, here are 20 example medical knowledge assessment questions about Lyme disease with focus on evidence-based clinical recommendations:\n\n1. What bacterial species causes Lyme disease?  \n2. What is the recommended antibiotic prophylaxis regimen for a high-risk tick bite?  \n3. What are the three criteria that define a high-risk tick bite warranting antibiotic prophylaxis?  \n4. What is the typical duration of antibiotic therapy for early localized Lyme disease presenting as erythema migrans?  \n5. Which antibiotics and treatment durations are recommended for erythema migrans?  \n6. How should an attached tick be removed to minimize risk of infection?  \n7. What neurological complications can occur in Lyme disease, and what are two common neurologic manifestations?  \n8. What is the recommended duration of antibiotic therapy for acute neurologic Lyme disease without parenchymal involvement?  \n9. When is laboratory testing recommended for diagnosis of Lyme disease in patients with erythema migrans?  \n10. What is the role of serum antibody testing in evaluating neurologic syndromes possibly caused by Lyme disease?  \n11. In which neurologic presentations is Lyme disease testing recommended?  \n12. When is Lyme disease testing not recommended in patients presenting with certain neurological or psychiatric disorders?  \n13. What pacing modality is recommended for symptomatic bradycardia caused by Lyme carditis that is unresponsive to medical treatment?  \n14. What clinical features characterize early localized Lyme disease?  \n15. What is the guideline stance on routine Lyme disease testing in children with developmental or behavioral disorders?  \n16. What is the recommended duration of oral antibiotic therapy for early disseminated Lyme disease manifestations like Lyme meningitis?  \n17. What is the importance of prompt tick removal in Lyme disease prevention?  \n18. What are the limitations of PCR or culture testing for Lyme disease diagnosis of neurologic involvement?  \n19. How should patients with suspected Lyme neuroborreliosis involving peripheral or central nervous system be tested?  \n20. What is the strength of recommendation and quality of evidence supporting the use of doxycycline for erythema migrans?\n\n---\n\n**Note:** Some topics such as the epidemiology, treatment of late or chronic Lyme disease, vaccine considerations, or management of Lyme arthritis beyond neurologic disease are not covered in the provided information and cannot be included.",
        "contexto": [
            "Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease  Roche Diagnostics  Abbott Laboratories (formerly St. Jude Medical  Centers for Medicare and Medicaid Services CMS  Michigan Department of Health and Human Services  Slovenian Research Agency  American Academy of Family Physicians AAFP  Global Lyme",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI.",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,",
            "migrans? Recommendations: 1. In patients with potential tick exposure in a Lyme disease endemic area who have 1 or more skin lesions compatible with erythema migrans, we recommend clinical diagnosis rather than laboratory testing (strong recommendation, moderatequality evidence). 2. In patients with 1 or more skin lesions suggestive of, but atypical for erythema migrans, we suggest antibody testing performed on an acute-phase serum sample (followed by a convalescent-phase serum sample if the"
        ]
    },
    {
        "pregunta": "14. What are the indications for intravenous antibiotic therapy in Lyme disease?",
        "respuesta": "Based on the provided guideline information, the indications for intravenous (IV) antibiotic therapy in Lyme disease include:\n\n- **Lyme disease-associated parenchymal involvement of the brain or spinal cord** (e.g., encephalitis, myelitis). In these cases, IV antibiotics are preferred over oral therapy due to the severity and site of infection.\n\n- Patients with **Lyme arthritis** who have failed at least one course of oral antibiotics and may require IV antibiotics as part of treatment escalation.\n\n- Cases where oral antibiotics are not tolerated, contraindicated, or where clinical severity dictates more intensive therapy.\n\nThe guidelines suggest that in early neurologic Lyme disease without parenchymal involvement (e.g., Lyme meningitis, cranial neuropathy, radiculoneuropathy), oral antibiotic therapy for 14 to 21 (or up to 28) days is appropriate, implying IV therapy is reserved for more severe or complicated cases.\n\n**Summary:** IV antibiotic therapy is indicated primarily in Lyme disease with central nervous system parenchymal involvement and in specific cases of Lyme arthritis requiring escalation beyond oral therapy. For most other manifestations without parenchymal involvement, oral antibiotics are recommended.\n\nIf you need further detail on specific regimens or durations, please specify.",
        "contexto": [
            "as side effect profile, ease of administration, ability to tolerate oral medication, concerns about compliance unrelated to effectiveness. Treatment route may be changed from IV to oral during treatment. The preferred antibiotic duration is 14-21 days. XIV. Should patients with Lyme disease-related parenchymal involvement of the brain or spinal cord be treated with oral or intravenous antibiotics? Recommendation: 1. In patients with Lyme disease-associated parenchymal involvement of the brain",
            "low-quality evidence). XXIV. How should post-antibiotic (previously termed antibiotic-refractory) Lyme arthritis be treated? Recommendation: 1. In patients who have failed 1 course of oral antibiotics and 1 course of IV antibiotics, we suggest a referral to a rheumatologist or other trained specialist for consideration of the use of disease-modifying antirheumatic drugs, biologic agents, intraarticular steroids, or arthroscopic synovectomy (weak recommendation, very low-quality evidence).",
            "arthroscopic synovectomy (weak recommendation, very low-quality evidence). Comment: Antibiotic therapy for longer than 8 weeks is not expected to provide additional benefit to patients with persistent arthritis if that treatment has included 1 course of IV therapy. XXV. Should patients with persistent symptoms following standard treatment of Lyme disease receive additional antibiotics? Recommendation: 1. For patients who have persistent or recurring nonspecific symptoms such as fatigue, pain,",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence). XXIII. What are the approaches to patients in whom Lyme arthritis has not completely resolved? Recommendations: 1. In patients with Lyme arthritis with partial response (mild residual joint swelling) after a first course of oral antibiotic, we make no recommendation for a second course of antibiotic versus observation (no recommendation, knowledge gap). Comment: Consideration should be given to"
        ]
    },
    {
        "pregunta": "15. Describe the geographic regions in the United States where Lyme disease is most endemic.",
        "respuesta": "The provided guideline information does **not** include specific details about which geographic regions in the United States are the most endemic areas for Lyme disease. Therefore, a reliable response to this question cannot be given based on the available data.",
        "contexto": [
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "for or against the use of antibiotics (no recommendation; knowledge gap). Comment: In certain geographic regions both STARI and Lyme disease are endemic . Distinguishing single erythema migrans due to Lyme disease from STARI may not be possible clinically unless the responsible tick has been identified IX. What is the preferred diagnostic testing strategy for Lyme neuroborreliosis? Recommendations: 1. When assessing patients for possible Lyme neuroborreliosis involving either the peripheral",
            "in the United States, as this duration of therapy was used in the largest clinical trial performed in the United States . VIII. Should patients with the southern tickassociated rash illness (STARI) be treated with antibiotics? Recommendation: 1. In patients who develop an erythema migrans-like skin lesion following the bite of the lone star tick (Amblyomma americanum), an illness referred to as STARI, we make no recommendation for or against the use of antibiotics (no recommendation; knowledge",
            "for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists, and dermatologists in North America. Summarized below are the 2020 recommendations for the prevention, diagnosis, and treatment of Lyme disease. The panel followed a systematic process used in the development of other Infectious Diseases Society of",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI."
        ]
    },
    {
        "pregunta": "16. Should patients with persistent nonspecific symptoms following standard Lyme disease treatment receive additional antibiotic therapy in the absence of objective evidence of reinfection or treatment failure?",
        "respuesta": "Patients who continue to experience persistent or recurring nonspecific symptoms such as fatigue, pain, or cognitive impairment after completing recommended treatment for Lyme disease, but who lack objective evidence of reinfection or treatment failure (e.g., arthritis, meningitis, or neuropathy), **should not receive additional antibiotic therapy**. This is a **strong recommendation** based on **moderate-quality evidence**.",
        "contexto": [
            "have persistent or recurring nonspecific symptoms such as fatigue, pain, or cognitive impairment following recommended treatment for Lyme disease, but who lack objective evidence of reinfection or treatment failure, we recommend against additional antibiotic therapy (strong recommendation, moderate-quality evidence). Comment: Evidence of persistent infection or treatment failure would include objective signs of disease activity, such as arthritis, meningitis, or neuropathy. XXVI. What is the",
            "arthroscopic synovectomy (weak recommendation, very low-quality evidence). Comment: Antibiotic therapy for longer than 8 weeks is not expected to provide additional benefit to patients with persistent arthritis if that treatment has included 1 course of IV therapy. XXV. Should patients with persistent symptoms following standard treatment of Lyme disease receive additional antibiotics? Recommendation: 1. For patients who have persistent or recurring nonspecific symptoms such as fatigue, pain,",
            "low-quality evidence). XXIV. How should post-antibiotic (previously termed antibiotic-refractory) Lyme arthritis be treated? Recommendation: 1. In patients who have failed 1 course of oral antibiotics and 1 course of IV antibiotics, we suggest a referral to a rheumatologist or other trained specialist for consideration of the use of disease-modifying antirheumatic drugs, biologic agents, intraarticular steroids, or arthroscopic synovectomy (weak recommendation, very low-quality evidence).",
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence). XXIII. What are the approaches to patients in whom Lyme arthritis has not completely resolved? Recommendations: 1. In patients with Lyme arthritis with partial response (mild residual joint swelling) after a first course of oral antibiotic, we make no recommendation for a second course of antibiotic versus observation (no recommendation, knowledge gap). Comment: Consideration should be given to"
        ]
    },
    {
        "pregunta": "17. How is Lyme disease diagnosed in patients presenting with late manifestations such as Lyme arthritis?",
        "respuesta": "In patients presenting with late manifestations such as Lyme arthritis, the guideline recommends:\n\n- **Serum antibody testing** as the preferred initial diagnostic method over PCR or culture of blood or synovial fluid/tissue (strong recommendation, moderate-quality evidence).\n\n- For seropositive patients in whom the diagnosis is still uncertain and treatment decisions require more definitive information, **PCR testing of synovial fluid or tissue** is recommended over Borrelia culture of those samples (strong recommendation, moderate-quality evidence).\n\nThus, diagnosis of Lyme arthritis primarily relies on serologic testing, with PCR of synovial fluid/tissue reserved for selected cases to confirm active infection.",
        "contexto": [
            "of unknown cause, we suggest against routine testing for Lyme disease (weak recommendation, low-quality evidence). XXI. What is the preferred diagnostic testing strategy for Lyme arthritis? Recommendations: 1. When assessing possible Lyme arthritis, we recommend serum antibody testing over PCR or culture of blood or synovial fluid/ tissue (strong recommendation, moderate-quality evidence). 2. In seropositive patients for whom the diagnosis of Lyme arthritis is being considered but treatment",
            "for whom the diagnosis of Lyme arthritis is being considered but treatment decisions require more definitive information, we recommend PCR applied to synovial fluid or tissue rather than Borrelia culture of those samples (strong recommendation, moderate-quality evidence). XXII. What are the preferred antibiotic regimens for the initial treatment of Lyme arthritis? Recommendation: 1. For patients with Lyme arthritis, we recommend using oral antibiotic therapy for 28 days (strong recommendation,",
            "low-quality evidence). XXIV. How should post-antibiotic (previously termed antibiotic-refractory) Lyme arthritis be treated? Recommendation: 1. In patients who have failed 1 course of oral antibiotics and 1 course of IV antibiotics, we suggest a referral to a rheumatologist or other trained specialist for consideration of the use of disease-modifying antirheumatic drugs, biologic agents, intraarticular steroids, or arthroscopic synovectomy (weak recommendation, very low-quality evidence).",
            "using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence). XXIII. What are the approaches to patients in whom Lyme arthritis has not completely resolved? Recommendations: 1. In patients with Lyme arthritis with partial response (mild residual joint swelling) after a first course of oral antibiotic, we make no recommendation for a second course of antibiotic versus observation (no recommendation, knowledge gap). Comment: Consideration should be given to",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,"
        ]
    },
    {
        "pregunta": "18. What is the preferred antibiotic regimen for chemoprophylaxis following a high-risk Ixodes tick bite?",
        "respuesta": "For chemoprophylaxis following a high-risk Ixodes spp. tick bite, the guideline **strongly recommends** administering a **single dose of oral doxycycline within 72 hours of tick removal** over observation. The dosing is:\n\n- **Adults:** 200 mg orally once  \n- **Children:** 4.4 mg/kg orally once (up to a maximum dose of 200 mg)  \n\nThis recommendation applies to all age groups and is based on moderate-quality evidence.",
        "contexto": [
            "a wait-and-watch approach is recommended. A tick bite is considered to be high-risk only if it meets the following 3 criteria: the tick bite was from (a) an identified Ixodes spp. vector species, (b) it occurred in a highly endemic area, and (c) the tick was attached for ≥36 hours. IV. What is the preferred antibiotic regimen for the chemoprophylaxis of Lyme disease following a high-risk tick bite? Recommendation: 1. For high-risk Ixodes spp. bites in all age groups, we recommend the",
            "1. For high-risk Ixodes spp. bites in all age groups, we recommend the administration of a single dose of oral doxycycline within 72 hours of tick removal over observation (strong recommendation, moderate-quality evidence). Comment: Doxycycline is given as a single oral dose, 200 mg for adults and 4.4 mg/kg (up to a maximum dose of 200 mg) for children. V. What is the preferred diagnostic testing strategy for erythema migrans? Recommendations: 1. In patients with potential tick exposure in a",
            "disease following presentation with a tick bite? Recommendation: 1. We recommend that prophylactic antibiotic therapy be given only to adults and children within 72 hours of removal of an identified high-risk tick bite, but not for bites that are equivocal risk or low risk (strong recommendation, high-quality evidence). Comment: If a tick bite cannot be classified with a high level of certainty as a high-risk bite, a wait-and-watch approach is recommended. A tick bite is considered to be",
            "activity, such as arthritis, meningitis, or neuropathy. XXVI. What is the preferred antibiotic regimen for the treatment of borrelial lymphocytoma? Recommendation: 1. In patients with borrelial lymphocytoma, we suggest oral antibiotic therapy for 14 days (weak recommendation, lowquality evidence). XXVII. What is the preferred antibiotic regimen for the treatment of acrodermatitis chronica atrophicans? Recommendation: 1. In patients with acrodermatitis chronica atrophicans, we suggest oral",
            "VI. What are the preferred antibiotic regimens for the treatment of erythema migrans? Recommendation: 1. For patients with erythema migrans, we recommend using oral antibiotic therapy with doxycycline, amoxicillin, or cefuroxime axetil (strong recommendation; moderate-quality evidence). Comment: For patients unable to take both doxycycline and beta-lactam antibiotics, the preferred second-line agent is azithromycin. VII. How long should a patient with erythema migrans be treated?"
        ]
    },
    {
        "pregunta": "19. Is routine antibiotic prophylaxis recommended after a tick bite? Under what conditions?",
        "respuesta": "Routine antibiotic prophylaxis is **not recommended** after every tick bite. Prophylactic antibiotic therapy is **strongly recommended only for patients (adults and children) with a high-risk tick bite**, provided the following three criteria are all met:\n\n1. The tick is an identified **Ixodes spp.** vector species.  \n2. The bite occurred in a **highly endemic area** for Lyme disease.  \n3. The tick was attached for **≥36 hours**.\n\nIf these criteria are met, a **single dose of oral doxycycline given within 72 hours of tick removal** is recommended as prophylaxis.\n\nFor tick bites that do not meet these high-risk criteria, a **wait-and-watch approach** is recommended rather than routine antibiotic prophylaxis. Testing or treating all removed ticks is not advised unless the risk criteria are fulfilled.\n\nIn summary, antibiotic prophylaxis should only be given selectively after confirmed high-risk Ixodes tick bites within 72 hours of removal.",
        "contexto": [
            "disease following presentation with a tick bite? Recommendation: 1. We recommend that prophylactic antibiotic therapy be given only to adults and children within 72 hours of removal of an identified high-risk tick bite, but not for bites that are equivocal risk or low risk (strong recommendation, high-quality evidence). Comment: If a tick bite cannot be classified with a high level of certainty as a high-risk bite, a wait-and-watch approach is recommended. A tick bite is considered to be",
            "a wait-and-watch approach is recommended. A tick bite is considered to be high-risk only if it meets the following 3 criteria: the tick bite was from (a) an identified Ixodes spp. vector species, (b) it occurred in a highly endemic area, and (c) the tick was attached for ≥36 hours. IV. What is the preferred antibiotic regimen for the chemoprophylaxis of Lyme disease following a high-risk tick bite? Recommendation: 1. For high-risk Ixodes spp. bites in all age groups, we recommend the",
            "Recommendations: 1. We recommend submitting the removed tick for species identification (good practice statement). are identical except for minor stylistic and spelling differences in keeping with each journal's style. The full guideline is available at http://onlin elibr ary. wiley.com/doi/10.1002/art.41562/ abstract We recommend against testing a removed III. Who should receive antibiotic prophylaxis to prevent Lyme disease following presentation with a tick bite? Recommendation: 1. We",
            "1. In patients with acrodermatitis chronica atrophicans, we suggest oral antibiotic therapy for 21-28 days over shorter durations (weak recommendation, low-quality evidence). XXVIII. Under what circumstances should a patient with Lyme disease be evaluated for coinfection with A. phagocytophilum or B. microti? Recommendation: 1 To provide thorough transparency, the IDSA/AAN/ACR requires full disclosure of all relationships, regardless of relevancy to the guideline topic. The assessment of",
            "in the United States, as this duration of therapy was used in the largest clinical trial performed in the United States . VIII. Should patients with the southern tickassociated rash illness (STARI) be treated with antibiotics? Recommendation: 1. In patients who develop an erythema migrans-like skin lesion following the bite of the lone star tick (Amblyomma americanum), an illness referred to as STARI, we make no recommendation for or against the use of antibiotics (no recommendation; knowledge"
        ]
    },
    {
        "pregunta": "20. What are common neurological complications of Lyme disease?",
        "respuesta": "Common neurological complications of Lyme disease, as per the provided guideline information, include:\n\n- **Lyme disease-associated meningitis**  \n- **Cranial neuropathy** (such as facial nerve palsy)  \n- **Radiculoneuritis** or painful radiculoneuritis  \n- Other peripheral nervous system (PNS) manifestations\n\nThese are the neurologic presentations for which Lyme disease testing is recommended. The guideline does not provide further details on additional neurologic complications.",
        "contexto": [
            "1. In children presenting with developmental, behavioral, or psychiatric disorders, we suggest against routinely testing for Lyme disease (weak recommendation, low-quality evidence). XIII. What are the preferred antibiotic regimens for the treatment of acute neurologic manifestations of Lyme disease without parenchymal involvement of the brain or spinal cord? Recommendation: 1. In patients with Lyme disease-associated meningitis, cranial neuropathy, radiculoneuropathy, or with other PNS",
            "Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists",
            "for possible Lyme neuroborreliosis involving either the peripheral nervous system (PNS) or central nervous system (CNS), we recommend serum antibody testing rather than PCR or culture of either cerebrospinal fluid (CSF) or serum (strong recommendation, moderate-quality evidence). X. For which neurologic presentations should patients be tested for Lyme disease? Recommendations: 1. In patients presenting with 1 or more of the following acute disorders: meningitis, painful radiculoneuritis,",
            "plausible exposure to ticks infected with B. burgdorferi, we recommend testing for Lyme disease (strong recommendation, moderate-quality evidence). 2. In patients with typical amyotrophic lateral sclerosis, relapsing-remitting multiple sclerosis, Parkinson's disease, dementia or cognitive decline, or new-onset seizures, we recommend against routine testing for Lyme disease (strong recommendation, low-quality evidence). 3. In patients with neurologic syndromes other than those listed in XI.",
            "have persistent or recurring nonspecific symptoms such as fatigue, pain, or cognitive impairment following recommended treatment for Lyme disease, but who lack objective evidence of reinfection or treatment failure, we recommend against additional antibiotic therapy (strong recommendation, moderate-quality evidence). Comment: Evidence of persistent infection or treatment failure would include objective signs of disease activity, such as arthritis, meningitis, or neuropathy. XXVI. What is the"
        ]
    }
]